Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f402002a3cb1b2a566a7639d0c9bad7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e63fd8d0672eef12c989bb227e7b8299 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06b5a98ca8d5390499810dbda3323965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb12566b6583a2fd77423983ea0d1c1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6445 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6858 |
filingDate |
1995-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99dca0430a074ee251ff2587f144250c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75dae3acf033a9788af752b52595b6b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad3780a4c19ab649d0deeaea9d685615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa6397548411c186bd5feac390bc59f8 |
publicationDate |
1995-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9528498-A1 |
titleOfInvention |
Method for molecular staging of prostate cancer |
abstract |
A method for enhancing the detection of prostate specific antigen in a biological sample comprising (a) extracting mRNA from the sample; (b) contacting the mRNA from step (a) with reverse transcriptase under conditions allowing for the production of cDNA; (c) contacting the cDNA from step (b) with a pair of reverse transcriptase polymerase chain reaction primers capable of specifically hybridizing with DNA encoding prostate specific antigen wherein one such primer is an oligonucleotide of 12 to 30 nucleotides in length and comprises the sequence 5-CACCCATCCTA-3' and wherein the second such primer is an oligonucleotide of 12 to 30 nucleotides in length and comprises the sequence 5'-TCCAGCCACGAC-3'; and wherein at least one of the primers is covalently linked to a modified digoxigenin molecule and under conditions allowing for extension of the primers; and (d) detecting the resulting amplified DNA. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6093796-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6103237-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752957-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9820117-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6897024-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11104958-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5858673-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7871986-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6171796-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8192931-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8241848-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551699-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8618276-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9815657-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1474528-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1474528-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7927806-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6479263-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7632643-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9937811-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6946133-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7960109-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7547773-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6235486-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9540696-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9845420-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9951390-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7138235-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9909189-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8178508-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2060630-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9821365-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0018961-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546551-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7655408-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5919638-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6110675-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0018961-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7368545-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7008765-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10006092-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9821365-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9846795-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8257924-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096907-B2 |
priorityDate |
1994-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |